MedPath

Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

Not Applicable
Completed
Conditions
Cystic Fibrosis
Interventions
Device: Bilevel
Device: PEP mask
Registration Number
NCT02083263
Lead Sponsor
Karolinska University Hospital
Brief Summary

With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).

Detailed Description

3 months intervention between PEP an Bilevel. The patients will follow up under 3 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Patients with CF older than 18 years
  • FEV1 between 20% and 69% of predictive.
  • No acute exacerbation.
  • No Burkhordelia Cepacia/MRSA colonization.
Exclusion Criteria
  • Children under 18 year
  • acute exacerbation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BilevelBilevelBilevel, 3 months. The treatment was performed twice a day, 1 hour each treatment.
PEP maskPEP maskPEP mask, 3 months. The treatment was performed twice a day, 1 hour each treatment.
Primary Outcome Measures
NameTimeMethod
Lung Function: Lung Clearance Indexup to 3 months

Lung clearance index was calculated as the number of lung volume turnovers (cumulative expired volume divided by the functional residual capacity) required to reduce end-tidal nitrogen concentration to 1/40th of the starting value.

Secondary Outcome Measures
NameTimeMethod
Blood Gases:1 Month After Chest Physiotherapy Will Take Blood Gases (Kpa).1 month

After physiotherapy will take blood gases (kpa) before chest physiotherapy and perform once a month.

Trial Locations

Locations (1)

Cecilia Rodriguez

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath